Provided by Tiger Trade Technology Pte. Ltd.

Eledon Pharmaceuticals, Inc.

2.98
-0.2200-6.88%
Post-market: 3.030.0498+1.67%19:26 EDT
Volume:1.83M
Turnover:5.52M
Market Cap:242.16M
PE:-3.02
High:3.18
Open:3.18
Low:2.93
Close:3.20
52wk High:4.60
52wk Low:1.35
Shares:81.26M
Float Shares:74.57M
Volume Ratio:1.86
T/O Rate:2.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9867
EPS(LYR):-0.5566
ROE:-110.71%
ROA:-39.02%
PB:3.36
PE(LYR):-5.35

Loading ...

Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Major Issues Report

Form 8-K - Current report
Apr 14, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Apr 07, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 31, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 31, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Major Issues Report

Form 8-K - Current report
Oct 02, 2024

Major Issues Report

Form 8-K - Current report
Sep 30, 2024

Correspondence

Form CORRESP - Correspondence